What's the next significant announcement ?, page-18

The trial parameters are set by the FDA, we have no say in that.All our supplies of cpn10 will be exhausted just doing the small trials required, hence the need for a partner who can foot the $5m required for the next batch.
If hot copper posts were still available for the CBio days you would quickly see why Novo walked.They asked for the innuendo and speculation re deals to cease on hot copper.So yes they did read Hot Copper.
There are still 30 interested parties waiting for results of the Lupus trial and maybe Novo could be one of them.Novo produce most of the worlds insulin supplies and I should imagine their interest would still be there as diabetes is an autoimmune disease-Definition of diabetes---"Insulin dependent diabetes mellitus (type 1) is an inflammatory autoimmune disease of the pancreas, resulting in a lack of insulin".